Stay updated with breaking news from Key therapies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
15+ key players and Out of all the emerging therapies, HBI-8000 is expected to capture the maximum patient pool owing to its immunomodulatory function. This oral agent targets class I histone deacetylase causing cell cycle arrest and tumor cell death as the mechanism underlying its single-agent activity against lymphoma. T-cell Leukemia pipeline comprises ASTX 660 (Otsuka Pharmaceutical) is in phase I/II while Valemetostat and Brentuximab vedotin (Seagen/Takeda) is in Phase II stage of development. HUYA Bioscience appears to have an upper edge as its therapy, HBI-8000 which is in the pre-registration phase. In April 2021, Shorla Pharma announced that the U.S. Food and Drug Administration (FDA) has accepted the filing application of its oncology drug ....
Global COPD Disease Market Insights and Market Forecasts Report 2020-2026 – ResearchAndMarkets.com financialbuzz.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialbuzz.com Daily Mail and Mail on Sunday newspapers.
ResearchAndMarkets.com’s offering. “Systemic lupus erythematosus (SLE): Disease Insights and Market Forecasts to 2026” report delivers an in-depth understanding of the disease, historical & forecasted epidemiology of Systemic lupus erythematosus (SLE) disease in the US, EU5 (Germany, France, Italy, Spain, UK), and Japan and the historical & forecasted market size, for Systemic lupus erythematosus (SLE), drug wise in $ sales and patient numbers at global level and in the US, EU5 (Germany, France, Italy, Spain, UK), Australia and Canada till 2026. Disease Indication Overview: This section of the report gives the overview of Systemic lupus erythematosus (SLE) disease indication in detail. The section highlights the basic definition, causes and symptoms of disease and details the types of Systemic lupus erythematosus (SLE) disease. Further details on the profile of Systemic lupus erythematosus (SLE) patients, Symptoms experienced by the patients, and disease progres ....
Disease Indication Overview: This section of the report gives the overview of Acne disease indication in detail. The section highlights the basic definition, causes and symptoms of disease and details the types of Acne disease. Further details on the profile of Acne patients, Symptoms experienced by the patients, and disease progression in patients are outlined in the report. The report further highlights the multiple methods through which the patient can be diagnosed for Acne disease. Epidemiology Forecasts to 2026: This section of the report provides the overview of Acne diagnosed prevalent and treated patients in the US, EU5 and Japan market year wise starting from 2018 till 2026. The epidemiology numbers in the report have been derived based on numerous studies, survey reports and views of key opinion leaders. ....